Join us on March 29th at 11am ET for a rare interview with GSK CEO Emma Walmsley on the race to bring the world's first RSV vaccine to market. We'll discuss new R&D spends, drug pipeline and pricing, and the appetite for M&A deals in 2023 and beyond.
Tidak ada komentar:
Posting Komentar